Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
Background & Aims: Currently available HDV PCR assays are characterized by considerable run-to-run and inter-laboratory variability. Hence, we established a quantitative reverse transcription real-time PCR (RT-qPCR) assay on the open channel of a fully automated PCR platform (cobas6800, Roch...
Enregistré dans:
Auteurs principaux: | Lisa Sophie Pflüger, Dominik Nörz, Tassilo Volz, Katja Giersch, Annika Giese, Nora Goldmann, Dieter Glebe, Jan-Hendrik Bockmann, Susanne Pfefferle, Maura Dandri, Julian Schulze zur Wiesch, Marc Lütgehetmann |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Elsevier
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/f3d9aadcae3c49dab7c4fe5a8f856e86 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Prevalence of anti HDV in HBV carriers in Babol during 2000-02
par: MR Hassanjani Roshan, et autres
Publié: (2004) -
MOLECULAR EPIDEMIOLOGY FEATURES OF HBV/HDV CO-INFECTION IN KYRGYZSTAN
par: A. V. Semenov, et autres
Publié: (2016) -
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
par: Katja Giersch, et autres
Publié: (2017) -
Comparación entre Xpert® y COBAS®-TaqMan® para la medición de carga viral de virus hepatitis B y C
par: Ramírez,Felipe, et autres
Publié: (2021) -
Cambios en la epidemiología de las hepatitis virales en Chile y consideraciones en estrategias de prevención
par: Ibarra V,Humberto
Publié: (2007)